Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon ReceptorSummary

Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon ReceptorSummary

Background & Aims: Mesalamine is a first-line drug for treatment of inflammatory bowel diseases (IBD). However, its mechanisms are not fully understood. CD4+ Foxp3+ regulatory T cells (Tregs) play a potential role in suppressing IBD. This study determined whether the anti-inflammatory activity o...

Full description

Bibliographic Details
Main Authors:	Kyoko Oh-oka, Yuko Kojima, Koichiro Uchida, Kimiko Yoda, Kayoko Ishimaru, Shotaro Nakajima, Jun Hemmi, Hiroshi Kano, Yoshiaki Fujii-Kuriyama, Ryohei Katoh, Hiroyuki Ito, Atsuhito Nakao
Format:	Article
Language:	English
Published:	Elsevier 2017-07-01
Series:	Cellular and Molecular Gastroenterology and Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352345X17300735

Similar Items

Ethyl Caffeate Can Inhibit Aryl Hydrocarbon Receptor (AhR) Signaling and AhR-Mediated Potentiation of Mast Cell Activation
by: Phuc-Tan Nguyen, et al.
Published: (2023-06-01)

Mesalamine induced eosinophilic pneumonia
by: Ankit Gupta, MD, MS, et al.
Published: (2017-01-01)

Psyllium Fiber Protects Against Colitis Via Activation of Bile Acid Sensor Farnesoid X ReceptorSummary
by: Alexis Bretin, et al.
Published: (2023-01-01)

Expressions of tight junction proteins Occludin and Claudin-1 are under the circadian control in the mouse large intestine: implications in intestinal permeability and susceptibility to colitis.
by: Oh-oka Kyoko, et al.
Published: (2014-01-01)

Residential Area, Birth Order, and Dietary Habit May Influence TSLP Levels in Colostrum: Comparative Study between Japan and Nepal
by: Yoko Aihara, et al.
Published: (2014-01-01)

Recent advances in mesalamine colonic delivery systems
by: Mohammad F. Bayan, et al.
Published: (2020-07-01)

Dietary resveratrol prevents the development of food allergy in mice.
by: Yui Okada, et al.
Published: (2012-01-01)

Gut-innervating TRPV1+ Neurons Drive Chronic Visceral Pain via Microglial P2Y12 ReceptorSummary
by: Manon Defaye, et al.
Published: (2022-01-01)

Electroanalytical Overview: The Sensing of Mesalamine (5-Aminosalicylic Acid)
by: Robert D. Crapnell, et al.
Published: (2023-12-01)

The culprit of mesalamine intolerance: case series and literature review
by: Cheng Xie, et al.
Published: (2019-07-01)

Once-Daily MMX Mesalamine in the Management of Ulcerative colitis
by: Wojciech Blonski, et al.
Published: (2011-01-01)

Oxidation of Mesalamine under Phenoloxidase- or Peroxidase-like Enzyme Catalysis
by: Rimaz El Zein, et al.
Published: (2023-12-01)

Treatment of lichen planus pemphigoides with mesalamine: novel use of this drug
by: Vijay Gandhi, et al.
Published: (2022-11-01)

Development of enteric coated sustained release minitablets containing mesalamine
by: Dayse Fernanda de Souza, et al.
Published: (2013-09-01)

Tackling the Threat of Cancer Due to Pathobionts Producing Colibactin: Is Mesalamine the Magic Bullet?
by: Min Tang-Fichaux, et al.
Published: (2021-12-01)

Simple and sensitive spectrophotometric methods for the analysis of mesalamine in bulk and tablet dosage forms
by: Bala Sekaran Chandra, et al.
Published: (2011-01-01)

Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine
by: Daniel B Zandman, et al.
Published: (2009-03-01)

Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis.
by: Christopher J Moran, et al.
Published: (2018-01-01)

Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers
by: Jakate A, et al.
Published: (2019-07-01)

The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
by: Travis, S, et al.
Published: (2013)

A Case of Stevens–Johnson Syndrome Complicated with Multimatrix System Mesalamine in Ulcerative Colitis
by: Mimari Kanazawa, et al.
Published: (2022-02-01)

Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach
by: Christophi GP, et al.
Published: (2016-05-01)

Response to Mesalamine Therapy in Pediatric Collagenous Gastritis and Colitis: A Case Report and Review
by: Ankit Mishra MS, et al.
Published: (2022-04-01)

Preparation and evaluation of magnetic microspheres of mesalamine (5-aminosalicylic acid) for colon drug delivery
by: Satinder Kakar, et al.
Published: (2013-01-01)

Exacerbation of Bloody Diarrhea as a Side Effect of Mesalamine Treatment of Active Ulcerative Colitis
by: Yuichi Shimodate, et al.
Published: (2011-04-01)

Nephrotic syndrome after treatment of Crohn′s disease with mesalamine: Case report and literature review
by: Belal M Firwana, et al.
Published: (2012-01-01)

Circadian Regulation of the Biology of Allergic Disease: Clock Disruption Can Promote Allergy
by: Atsuhito Nakao, et al.
Published: (2020-06-01)

Fulminant organizing pneumonia in a patient with ulcerative colitis on mesalamine and infliximab: striving to identify the cause!
by: Lídia Gomes, et al.
Published: (2023-07-01)

One of the 5-aminosalicylates drug, mesalamine as a drug repurposing lead against breast cancer
by: Dayanand Swami, et al.
Published: (2022-09-01)

OPTIMIZATION AND IN VIVO EVALUATION OF MESALAMINE pH DEPENDENT COATED PELLETS FOR PROMISING ILEOCECAL TARGETING
by: Hemant H Gangurde, et al.
Published: (2013-10-01)

Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis
by: Cuffari C, et al.
Published: (2016-02-01)

Update on the role of modified release mesalamine in the management of ulcerative colitis and Crohn&rsquo;s disease
by: Glen A Doherty, et al.
Published: (2009-12-01)

Maintaining remission in ulcerative colitis &ndash; role of once daily extended-release mesalamine
by: Lilliana Oliveira, et al.
Published: (2011-02-01)

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX&reg; mesalamine
by: Nanda K, et al.
Published: (2012-07-01)

Simple one-pot green method for large-scale production of mesalamine, an anti-inflammatory agent
by: Vijaya Lakshmi C., et al.
Published: (2019-01-01)

A novel pH–enzyme-dependent mesalamine colon-specific delivery system
by: Jin L, et al.
Published: (2016-06-01)

Immunoregulatory Effects of Elemental Diet and Its Ingredient, Tryptophan, via Activation of the Aryl Hydrocarbon Receptor in Mice
by: Atsuhito Kubota, et al.
Published: (2024-03-01)

Probiotic Supplementation and Human Milk Cytokine Profiles in Japanese Women: A Retrospective Study from an Open-Label Pilot Study
by: Tomoki Takahashi, et al.
Published: (2021-06-01)

Clock-dependent temporal regulation of IL-33/ST2-mediated mast cell response
by: Takahiro Kawauchi, et al.
Published: (2017-07-01)

Effects of Probiotic Supplementation on TGF-β1, TGF-β2, and IgA Levels in the Milk of Japanese Women: An Open-Label Pilot Study
by: Tomoki Takahashi, et al.
Published: (2019-09-01)